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Abstract
Background: It has long been thought that mammalian cardiomyocytes are terminally-differentiated and unable to
proliferate. However, myocytes in more primitive animals such as zebrafish are able to dedifferentiate and proliferate to
regenerate amputated cardiac muscle.
Methodology/Principal Findings: Here we test the hypothesis that mature mammalian cardiomyocytes retain substantial
cellular plasticity, including the ability to dedifferentiate, proliferate, and acquire progenitor cell phenotypes. Two
complementary methods were used: 1) cardiomyocyte purification from rat hearts, and 2) genetic fate mapping in cardiac
explants from bi-transgenic mice. Cardiomyocytes isolated from rodent hearts were purified by multiple centrifugation and
Percoll gradient separation steps, and the purity verified by immunostaining and RT-PCR. Within days in culture, purified
cardiomyocytes lost their characteristic electrophysiological properties and striations, flattened and began to divide, as
confirmed by proliferation markers and BrdU incorporation. Many dedifferentiated cardiomyocytes went on to express the
stem cell antigen c-kit, and the early cardiac transcription factors GATA4 and Nkx2.5. Underlying these changes, inhibitory
cell cycle molecules were suppressed in myocyte-derived cells (MDCs), while microRNAs known to orchestrate proliferation
and pluripotency increased dramatically. Some, but not all, MDCs self-organized into spheres and re-differentiated into
myocytes and endothelial cells in vitro. Cell fate tracking of cardiomyocytes from 4-OH-Tamoxifen-treated double-transgenic
MerCreMer/ZEG mouse hearts revealed that green fluorescent protein (GFP) continues to be expressed in dedifferentiated
cardiomyocytes, two-thirds of which were also c-kit
+.
Conclusions/Significance: Contradicting the prevailing view that they are terminally-differentiated, postnatal mammalian
cardiomyocytes are instead capable of substantial plasticity. Dedifferentiation of myocytes facilitates proliferation and
confers a degree of stemness, including the expression of c-kit and the capacity for multipotency.
Citation: Zhang Y, Li T-S, Lee S-T, Wawrowsky KA, Cheng K, et al. (2010) Dedifferentiation and Proliferation of Mammalian Cardiomyocytes. PLoS ONE 5(9):
e12559. doi:10.1371/journal.pone.0012559
Editor: Alicia J. Kowaltowski, Instituto de Quı ´mica - Universidade de Sa ˜o Paulo, Brazil
Received April 15, 2010; Accepted August 5, 2010; Published September 3, 2010
Copyright:  2010 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the NIH Grant R01HL083109 (to E.M.). Y.Z. was funded by the Heart and Stroke Foundation of Canada Research Fellowship.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Dr. Marba ´n is a founder and equity holder in Capricor Inc. Capricor provided no funding for the present study. The remaining authors
report no conflicts.
* E-mail: Eduardo.Marban@csmc.edu
¤ Current address: Division of Cardiology, Kaohsiung Medical University, Kaohsiung City, Taiwan
Introduction
Generations of physicians have been taught that the heart is a
static organ, incapable of self-renewal. That dogma has been
undermined by the recognition that the adult mammalian heart
contains its own reservoir of progenitor (or stem) cells [1–5].
Cardiomyocytes in the human heart are renewed throughout life
[6]. In contrast to the prevailing view for mammals, hearts from
amphibians and zebrafish exhibit surprising potential to regenerate
cardiac muscle by partial dedifferentiation [7,8], and possibly by
stem cell-mediated regeneration as well [9]. Dedifferentiation can
change the phenotype of specialized cells, rendering them closer to
their ancestors with augmented plasticity. For instance, quail
pigment cells derived from neural crest can dedifferentiate to
become multipotent self-renewing progenitors expressing early
neural marker genes Sox10, FoxD3, Pax3 and Slug, and give rise to
glial cells and myofibroblasts [10]. Human chondrocytes, epidermal
cells, pancreatic beta cells and adipose stromal cells dedifferentiate
and exhibit stem cell phenotypes [11–15]. Dedifferentiation is a
common occurrence in plants; protoplasts from tobacco leaves
undergo a transitory phase conferring pluripotentiality, that
precedes signal-dependent re-entry into the cell cycle [16].
In adult cardiomyocytes, dedifferentiation has been investigated
extensively at the phenotypic level, mainly in non-purified cell
culture. In this study, we investigated dedifferentiation of adult
atrial and ventricular myocytes and their subsequent phenotype in
vitro using purified cardiomyocytes as one approach, and a genetic
myocyte fate mapping model as a complementary methodology to
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12559validate the main conclusions. The salient results are: 1)
downregulation of cell cycle inhibitors, 14-3-3, p21 and p53
underlies cardiomyocyte dedifferentiation; 2) dedifferentiated
cardiomyocytes divide and generate cardiac progenitor-like cells
that express c-kit. The results indicate substantial, unexpected
cellular plasticity of postnatal mammalian cardiomyocytes.
Formation of new cardiomyocytes may come from both the
proliferation of dedifferentiated myocytes without complete
reversion to a cardiac progenitor state [17], or by the cardiac
differentiation of stem cells (of embryologic or dedifferentiated
origin). Several preliminary reports have appeared [18–20].
Results
Dedifferentiation of Cardiomyocytes
As cardiac fibroblasts and other non-cardiomyocytes can
potentially affect cell cycle activity, it is necessary to eliminate those
cells when attempting to specifically study myocytes [21–23]. We
performed multiple steps in sequential sedimentation, Percoll
gradient centrifugation and preplating of rat cardiomyocytes
(Figure 1A). Cell preparations were evaluated for purity by the
expression of cardiac myofilament proteins as affirmative markers,
as well as for c-kit or other non-cardiomyocyte antigens as negative
markers [2,3,24]. As an alternative to flow cytometry, which is not
well-suited for cells as large as adult cardiomyocytes (usual maximal
nozzle size is 100 mm) [25], we employed high-density tile scanning
confocal microscopy: myocyte preparations of more than 100,000
cells were cyto-spunonto 22 mm culture glasses. No cells expressing
c-kit (a resident cardiac stem cell marker), CD31 (PECAM, an
endothelial cell marker), CD34 (an endothelial progenitor cell
marker) or CD90 (a mesenchymal stem cell marker) were observed
in purified cardiomyocyte samples containing as many as 500,000
counted cells (Figure S1) [2]. Transcripts for various non-myocyte
antigens were likewise undetectable in purified cardiomyocytes
(Figures 1B and 1C). Thus, by tile scanning microscopy, we can set
an upper limit for non-myocyte contamination of 1 in 500,000 cells
in the starting myocyte cultures. The PCR confirms the purity,
albeit with lower sensitivity (Figure S2).
Individual cardiomyocytes, cultured on grid-marked coverslips
continuously in mitogen-rich medium and observed over time,
spontaneously flattened and lost their striations (Figure 1A). By 6–
8 days, myocytes began to divide while completely losing their
distinctive cardiac electrical phenotype: the inward rectifier
potassium current (IK1) virtually disappeared, resting membrane
potential became depolarized, and cells shrank as revealed by
decreased electrical capacitance (Figure 2). Some dedifferentiated
myocytes no longer expressed myofilament cardiac troponin T
(cTnT) (Figure 3A).
Cell Cycle Progression of Cardiomyocytes
Although dedifferentiation and cell cycle reprogramming have
been studied extensively in myocytes from amphibians and
zebrafish [26–28], the processes are poorly understood in
Figure 1. Cardiomyocyte Dedifferentiation. A, Purified myocytes in prolonged culture dedifferentiate and round up and tend to divide. B-C, RT–
PCR amplification of cardiac, non-cardiac andstemcell markers. 30–35 3-step cycleswere used. H, heart tissue;BM,bone marrow cells;VS,blood vessels;
AP and VP, purified atrial and ventricular cardiomyocytes, rep.; Myo, purified myocytes; MDC, myocyte-derived cells; Sphere, MDC-formed spheres.
doi:10.1371/journal.pone.0012559.g001
Mammalian Myocyte Plasticity
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12559mammalian cardiomyocytes [22,29]. We analyzed cell cycle
progression in this cell culture model by studying the active cell
cycle markers Ki67, histone H3 and BrdU incorporation by
immunocytochemistry. Ki-67 is a vital molecule for cell prolifer-
ation that is expressed in proliferating cells during the active cell
cycle, but is absent in resting (G0 phase) cells. After 2d in culture,
1168% and 662% of atrial and ventricular myocytes, respec-
tively, re-entered the active cell cycle and expressed Ki-67, with
gradually increasing levels, reaching 80611.9% and 46611% at
11d for atrial and ventricular myocytes, respectively (p,0.001)
(Figure 3C). We assessed the proportion of myocytes entering S
phase by incubating the cells with BrdU for various periods. Cells
in M phase were detected using an antibody against phospho-
histone H3 at S10 (H3P). We found a progressive increase in the
numbers of BrdU– and H3P– positive cells, reaching a maximum
at about 1 week. The proportion of BrdU– and H3P– positive cells
was always higher in cultures of atrial myocytes than in those of
ventricular myocytes (Figure 3C). Figure 3A shows a dedifferen-
tiated heart cell, still expressing weakly the myofilament protein
troponin T (cTnT), budding off a smaller round cell that does not
express cTnT, while both have BrdU incorporated and express the
mitotic marker Aurora B Kinase in the cell cleavage furrow.
Moreover, we also found cells in prophase, anaphase, and
telophase (Figure S3), implicating the progression of myocyte
proliferation after dedifferentiation.
To further decipher the mechanisms underlying cell cycle
progression and the apparent differences between atrial and
ventricular myocytes, we investigated the expression of various
critical checkpoint regulators (14-3-3 (YWHAH), p21 and p53) by
immunocytochemical detection of cells cultured for 5 days [26].
Expression of the negative cell cycle regulator 14-3-3 has been
shown to prevent cell cycle progression and serum-induced
proliferation [30,31]. As predicted, the expression of 14-3-3g,a n
abundant isoform in the heart, was lower in freshly-isolated atrial
myocytes than in ventricular myocytes. Furthermore, on day 5 (the
most robust period of cell cycle progression for both types of cells),
expression of 14-3-3g was dramatically reduced (Figure 4A). p21
(WAF1/CIP1), a downstream target of 14-3-3 and a key inhibitory
factor involving in all phases of the cell cycle [32], was also
reduced in cultured dedifferentiating/proliferating myocytes. Its
endogenous level was 61% higher in freshly-isolated ventricular
myocytes than in atrial myocytes. Furthermore, p53was expressed
at much lower levels in fresh atrial myocytes than in ventricular
myocytes, and decreased over time in atrial myocytes (but not
much in ventricular myocytes) (Figures 4B and 4C). Taken
together, the data suggest that the weaker inhibitory signals in
atrial myocytes facilitate their progression into the cell cycle;
diminution of the inhibitory factors over time in both atrial and
ventricular myocytes underlies cell cycle progression and prolifer-
ation during dedifferentiation.
Dedifferentiated Cardiomyocytes Express Cardiac
Progenitor Cell Markers
Myocytes cultured at the ‘‘normal’’ density of 6,000–9,000
cells/cm
2, and maintained in continuous (prolonged) culture, went
on to yield small, round cells (Figure 5A). Because such cells
emerge from confluent cultures, proliferate and have the
morphological appearance and size of cardiac progenitor cells
[2,33], we dubbed them myocyte-derived cells (MDCs) and
subjected them to further characterization. As dedifferentiation
can subsequently contribute to tissue regeneration [10], we
investigated the possibility that MDCs may recapitulate at least
some of the features of cardiac progenitor cells (CPCs).
As shown in Figure 5, fresh cardiomyocytes are isolated, long
striated cells (Figure 5A.1d); over time (Figure S4), they become
confluent flat cells decorated by a cap of small, round phase-bright
myocyte-derived cells (MDCs; Figure 5A.7d, 12d). MDCs had
undetectable expression of cardiac filament a-MHC, while they
stained strongly positive for the stem cell marker c-kit (Figure 5B),
although no c-kit was detectable in the founder cardiomyocyte
population (Figure 5B.1d, Figures 1B–1C, 5C, and Figure S1). In
pure myocyte cultures, 2.3–3.1% of dedifferentiated surviving
myocytes in monolayers were c-kit
+ by immunostaining. The semi-
adherent cells derived from myocyte culture were also c-kit
+, albeit
weakly (Figure 5B.12d ‘‘non-adherent cells’’). RT-PCR for various
transcripts revealed that a-MHC, a signature of mature cardio-
Figure 2. Electrophysiological Dedifferentiation of Cardiomyocytes. A, Example recordings of inward rectifier potassium current (IK1)
normalizedtocellcapacitanceinfreshly-isolated(Ctl)and4 dor7 dculturedmyocytes, andinmyocyte-derivedcells(MDC).Inset isthevoltageprotocol
forIK1recording. B,Current-voltage(I-V) relationship ofIK1in Ctlor cultureddedifferentiatedmyocytesorinMDCs.Cell numbers aredenotedin brackets.
C, Resting membrane potential (RMP); D, Electrical capacitance as a means to measure cell size.
* P,0.001 vs. Ctl,
+ P,0.001 vs. MDC.
doi:10.1371/journal.pone.0012559.g002
Mammalian Myocyte Plasticity
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12559myocytes, went down in MDCs but rebounded in spheres;
conversely, c-kit was undetectable in fresh purified cardiomyocytes,
rich in MDCs, but sparse in spheres (Figures 1B–1C, and 5C). Sca-
1 was non-detectable in MDCs (data not shown). MDCs also
expressed CD90 transcript (for mesenchymal stem cell) as revealed
by RT-PCR (Figure 1B) but not at protein level (data not shown).
Figure 4. Expression of Regulatory Cell Cycle Factors in Cardiomyocytes. Expression level of inhibitory cell cycle factors 14-3-3g (A), p21 (B)
and p53 (C) in freshly isolated (Ctl) or in 5 d cultured atrial (Atr) and ventricular (Vent) myocytes, as measured by the fluorescence intensity in each
cell.
* P,0.01 vs. Ctl of Atr or Vent;
+ P,0.01 vs. Ctl Atr.
doi:10.1371/journal.pone.0012559.g004
Figure 3. Cell Cycle Progression in Cardiomyocytes. A, Fluorescent immunostaining reveals myocyte dedifferentiated and undergoing
cytokinesis as indicated by the expression of Aurora B kinase (Aurora B, green) in the cell cleavage furrow between one cell expressing cTnT (cell a,
red) and the other no cTnT (cell b), while both having BrdU incorporated (pseudo-white). Nuclei are stained with DAPI (blue). Scale bars, 20 mm. B,
Example immunofluorescent confocal images of tracked myocytes expressing proliferation markers Ki67 (green), phosphor-S10 histone H3 (H3P, red).
Scale bars, 20 mm. C, Time course of expression of active cell cycle indices Ki67, H3P, and BrdU incorporation as percentages of myocytes in
continuous culture.
* P,0.05;
+ P,0.001 for atrial (Atr) vs. ventricular (Vent) myocytes; n=151–380 cells for different time points.
doi:10.1371/journal.pone.0012559.g003
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RNAs (miRNAs) in MDCs as compared to fresh cardiomyocytes.
Notably, cardiac-specific miR-1, miR-133, miR-208 and miR-499
were all suppressed by two or more orders of magnitude [34,35],
as were the stemness and cell cycle repressors miR-141 and miR-
137 [36]; in contrast, the proliferative miRNAs, miR-222 [37],
increased dramatically in MDCs, and miR-221 was undetectable
in myocytes but highly expressed in MDCs (Figure 5D). The
pattern is consistent with cardiac dedifferentiation, cell cycle
progression and re-acquisition of a progenitor cell phenotype;
later, MDCs spontaneously re-differentiate as they form spheres, a
conjecture consistent with the observed changes in myocardial
transcripts Nkx2.5 and GATA4 (Figure 1C).
Re-Differentiation of Myocyte-Derived Cells
To study the re-differentiation process in more detail, we
characterized the properties of MDC-formed spheres. When
MDCs above the culture layer become more confluent, 20–40%
self-organized into spheres after 3–5 days in continued culture
(Fig. 6A). Spheres detached spontaneously (Figure 6A.2) and often
contracted rhythmically (Figure S4C; Movie S1–S4), signifying
competent excitation-contraction coupling. Moreover, confocal
imaging revealed that spheres not only express a-MHC (Figure 6B)
but also the cardiac gap-junction protein Cx43, as well as the
endothelial marker CD31 (Figure 4C). Transduction of MDC-
formed spheres with lentivirally-encoded eGFP driven by the
cardiac a-MHC promoter revealed remarkable green fluorescence,
in line with their contractile activity and apparent ability to re-
differentiate (Figure S5, Movie S5, and Figure 6). One notable
feature is the ability of source cardiomyocytes, uncontaminated by
endothelial cells or CSCs (Figures 1 and S1), to yield endothelial
cells as revealed by the expression of CD90, CD34 and CD31
(Figures 1B and 6C). This finding manifests the in vitro multilineage
potential of MDCs.
Genetic Cell Fate Mapping of Cardiomyocytes
The data presented thus far, although highly suggestive, hinge
on the purity of the starting preparation of cardiomyocytes. We
thus sought independent verification, by genetic fate mapping
using double transgenic MerCreMer/ZEG mice, of the notion
that adult mammalian cardiomyocytes can dedifferentiate into c-
kit
+ cells [38]. MerCreMer mice carry a fusion transgene of Cre
recombinase flanked by Mer (mutated estrogen receptor ligand-
binding domains) that is driven by a cardiac a-MHC promoter
(encoded by Myh6); thus the Cre recombinase activity is
tamoxifen-sensitive and cardiomyocyte-specific [39]. Additionally,
ZEG reporter mice carry lacZ transgene flanked by LoxP sites,
followed by stop codons and then eGFP gene [40]; therefore, upon
Figure 5. Dedifferentiated Cardiomyocytes Express c-kit. A, Continuous culture of purified myocytes become confluent and give rise to small,
phase-bright cells (myocyte-derived cells, MDCs) above the cell layers at about two weeks. Shown are typical images of myocyte cultures at 1 d, 7 d
and 12 d. B, Fluorescent immunostaining on cells corresponding to the time shown in (A), revealing the purity of myocyte cultures (1 d) that are
positive to a-MHC (green) but negative to c-kit; c-kit (red) emerges in the confluent layer (7 d, 12 d) and in the semi-adherent MDCs (12 d; 61620%,
n=3 cultures). Scale bars, 100 mm. C, Semi-quantified expression levels of a-MHC and c-kit detected by RT-PCR in isolate myocytes, non-adherent
MDCs (MDC), and MDC-formed spheres (Sphere). Densitometric values were normalized to b-actin (arbitrary unit); n=3. D, Expression levels of
regulatory miRNAs in MDCs as compared to freshly isolated myocytes (Myo). Comparative 2
2DDCt method was used; n=3.
doi:10.1371/journal.pone.0012559.g005
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recombinase activity, the reporter will switch to GFP (driven by b-
actin promoter), permanently marking cardiomyocytes and their
progeny as GFP-positive (Figure 7A). Cardiomyocytes were
identified unambiguously in explants of MerCreMer/ZEG
bitransgenic tamoxifen-pulsed mouse hearts by virtue of their co-
expression of GFP and cardiac myofilament cTnT (but not c-kit)
after a-MHC-promoter-driven gene recombination (Fig 7C)
[20,38]. The fidelity of this cardiac Cre/LoxP system was also
confirmed by genotyping showing that the floxed LacZ gene
(encoding b-galactosidase) was excised in GFP
+ myocytes after
gene recombination induced by 4-OH tamoxifen (Figure 7B) [20].
To check the myocyte dedifferentiation ex vivo, we modified the
tissue culture technique to attain better viability of mouse
myocytes [4,20]. As reported [4,24], small chunks of plated
ventricle spontaneously shed ‘‘outgrowth’’ cells. Early on (5 days
post-plating), the outgrowth of tamoxifen-pulsed bitransgenic mice
contains ,6% c-kit
+ cells, but no GFP
+ cells [20]. After 10 days in
culture, however, surviving GFP
+ cells within the explant and the
surrounding outgrowth had begun to round up, giving rise to
progeny in which some were weakly c-kit
+; the changes were
unequivocal by 3 weeks in culture (Figure 8), at which time many
GFP
+ cells had become c-kit
+. We quantified these observations by
counting cells in 10 different fields from 8–10 separate outgrowth
samples in 2 microscopic views distant from the cardiac explant
(Figures 8B–8C). c-kit
+ cells were either GFP
+ or GFP
2, and some
GFP
+ cells lacked c-kit expression; thus, both resident CPCs
(GFP
2) and MDCs (GFP
+) contribute to the c-kit
+ cell population
[1,41,42].
Discussion
Although the concept of dedifferentiation of a specialized cell
precedes the antibiotic era [43], cell fate was generally believed to
be unidirectional and irreversible. Mounting evidence now
supports the notion that various types of functionally-specialized
cells can change their fate under the influence of environmental
factors. Examples include amphibian hearts and limbs, and
zebrafish hearts, that, upon amputation, regenerate the lost parts
by a combination of dedifferentiation [7,8,28,44], activation of
stem cells [9], and cell-cycle re-entry without full dedifferentiation
[17]. Dedifferentiated myocytes flatten and spread out in culture
[45,46]; sarcomeres become ill-defined and disorganized, and the
expression of contractile proteins is dramatically altered [47,48].
Figure 6. Re-differentiation of Myocyte-Derived Cells (MDCs). A, MDC-formed spheres loosely adhere on the myocyte culture layer (1)o r
detach and become suspended, and eventually beat spontaneously (Supplemental Movies S1–S4); (2) Freshly harvested MDC sphere seeded onto
culture slide; (3) MDC sphere flattened on the culture vessel with cells crawling off the sphere 3 hr after plating. Scale bar, 100 mm. B, Confocal images
of fluorescent immunohistochemistry showing the expression of cardiac markers a-MHC (red), and stem cell marker c-kit (green). C, Expression of
Cx43 (green) and CD31 (red) in another MDC-formed sphere. Scale bars, 50 mm.
doi:10.1371/journal.pone.0012559.g006
Mammalian Myocyte Plasticity
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described in vivo, in fibrillating atria [49], in chronically-ischemic
myocardium, and in the border zone of myocardial infarcts [50].
Such dedifferentiated myocytes are not apoptotic and presumably
reflect adaptations to abnormal myocardial stress and/or perfusion
[51]. Indeed, dedifferentiated myocytes in continuous culture in
the present study were not apoptotic as verified by TUNEL assay
(data not shown). In multicellular organisms, dedifferentiation is
an important process underlying regeneration and the formation
of new stem cell lineages [52]. We have demonstrated that muscle
cells from the adult mammalian heart can dedifferentiate and
produce cells with antigenic and morphologic features of the
cardiac progenitor phenotype.
The cell culture system
To specifically address the issue of myocyte dedifferentiation
and proliferation, we employed multiple centrifugation steps and
Percoll gradient separation, resulting in highly-pure myocytes
(Figure 1, and Figures S1–S2). This minimizes possible contam-
ination by resident CPCs, and removes nonmyocyte cells that may
be capable of transdifferentiation, such as fibroblasts and
endothelial cells, as well as any resident CPCs that may have
been present in the initial isolates.
Previous work on cardiomyocyte dedifferentiation reported the
morphological changes that we describe in early culture [48], but
stopped short of observing cell cycle re-entry and acquisition of
‘‘stemness’’. Those studies used cytosine arabinoside (AraC) or other
inhibitors to suppress the growth of nonmyocytes [29,49,53], which
may also have stopped or delayed cell cycle progression of
cardiomyocytes. In pilot studies, we noticed that AraC dramatically
suppressedcell cycle progression in atrial myocyteseven 3 daysor more
after its removal from culture medium, and the H3P index was
reduced from 7561 2 %a td a y5t o3 4 611% (p,0.001) at day 9. In
our experiments, the higher Ki67-, BrdU- and H3P-indices as
compared to previous studies, might be due to such key differences
in culture conditions. In addition, after the removal of dead and
detached cells in the first few days of culture, the culture medium was
changed much less frequently here than in previous studies. Self-
conditioned medium may provide positive feedback for cell cycle
progression and transformation of cell fate; we are now exploring this
concept. Furthermore, the change of culture medium in previous
studies might also remove proliferating myocytes and emerging MDCs
that are semi-adherent and exhibit progenitor cell phenotypes.
We noted that, within the first 2–3 days, 20–30% myocytes were
lost during the change of medium to remove dead and
nonattached cells. The cell culture became stable thereafter; this
phenomenon also happened in explant culture of bi-transgenic
cardiac tissue (Figure 8A.0d and 7d) and presumably reflects
apoptosis of some myocytes in the early period. Therefore, we
speculate that dedifferentiation may function as a reprogrammed
survival mechanism for stressed cardiomyocytes [54]. Such a
mechanism may help rationalize the unusually high prevalence of
c-kit
+ cells in failing human myocardium [55], a setting rich in
‘‘hibernating’’ dedifferentiated myocytes [56].
Dedifferentiated cardiomyocytes give rise to progenitor
cells
Using low-density culture on grid-marked coverslips, and
normal dense culture, we were able to characterize dedifferenti-
ation in both single myocytes and in myocyte pools. Most of the
cardiomyocytes were in a quiescent G0 phase, evidenced by a low
Ki67 index even after one day in culture. 14-3-3 and p21 are
Figure 7. Generation of MerCreMer-Z/EG Bi-Transgenic Mice. A, Cardiomyocytes and their progeny will constitutively express eGFP reporter
gene driven by b-actin promoter (b-Act) after the excision of floxed lacZ mediated by tamoxifen-sensitive Cre that is under the control of full length
cardiac a-MHC (MYH6) promoter. B, PCR detection on transgenes MerCreMer, LacZ, GFP, and internal control (IL-2) in isolated GFP myocytes, and GFP
+-
or GFP
2–MDC demonstrating the cardiac specific-gene recombination induced by tamoxifen. C, Fluorescent immunocytochemistry revealed that
cardiomyocytes from 4-OH-Tamoxifen-treated bi-transgenic MerCreMer-Z/EG mice are positive to both GFP (green) and cardiac marker cTnT (red),
but not to stem cell marker c-kit. Nuclei were counterstained with DAPI (Blue). Scale bar, 100mm.
doi:10.1371/journal.pone.0012559.g007
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the p53–p21 pathway facilitates the generation of induced
pluripotent stem (iPS) cells [26,57]. While we have not excluded
the possibility that reactivation of positive regulators of cyclins and
cyclin-dependent kinases might contribute to cell cycle re-entry in
adult myocytes [29], the present study implicates relief of
constraint from the 14-3-3/p21/p53 pathway in the enhanced
proliferative potential of dedifferentiating myocytes.
Recent studies in mice and in zebrafish revealed partial
dedifferentiation in vivo, evident by disassembly of sarcomeres
prior to cell proliferation [7,8,17]. We have found that
mammalian cardiomyocytes in long-term culture undergo much
more extensive dedifferentiation, as evidenced by the loss of typical
cardiomyocyte morphology, cardiac filament protein and tran-
scripts, and characteristic electrophysiological properties, with
subsequent re-expression of the progenitor cell marker c-kit. The
reacquisition of a progenitor/stem cell phenotype in dedifferen-
tiated myocytes was further verified in an ex vivo cardiac tissue
culture setting by Cre/LoxP cell fate mapping of GFP-positive
myocytes and their progeny [3,38,40,58,59]. The orchestrated
expressions of cardiac, proliferative, cell cycle and stemness
regulatory miRNAs, and related proteins and mRNAs, are
consistent with the proposed progenitor/stem cell identity of
MDCs. The re-differentiation potential of MDCs further confirms
the identity of MDCs as cardiac progenitor/stem cells.
Limitations
Either of two complementary approaches independently leads
to the conclusion that cardiomyocyte dedifferentiation produces
CPCs. Both approaches would have to be fundamentally flawed in
order to invalidate the concept. Specifically, the starting
cardiomyocyte preparation would have to be substantially impure,
and the bitransgenic mice would have to be misleading reporters
of the cardiomyocyte lineage. We will consider each of these two
possibilities in turn.
To purify cardiomyocytes, we adopted multiple sedimentation
and Percoll gradient separation steps, and then evaluated purity by
various assays. Real-time RT-PCR, capable of detecting 1
contaminating c-kit
+ cell per 40,000 cardiomyocytes, revealed that
nonmyocytes were undetectable in our preparation. An even more
sensitive approach, high-density tile scanning confocal microscopy,
supported the notion of cardiomyocyte purity, at least within a
resolution limit of 1 in 500,000. Given that there is on average one
CPC per 10,000 myocytes in the rat heart [2], even a native tissue
level of contamination, with no purification, would have fallen well
within the detection limit of our methods. Moreover, isolated c-kit
+
CPCs exhibit very slow proliferative activity in vitro [41], making it
unlikely that contaminating CPCs in the starting material, even if
present, could account for what we have called MDCs.
Genetic cell fate mapping to track cardiomyocytes and their
progeny depends on the fidelity of the a-MHC promoter, which has
Figure 8. Genetic Cell Fate Mapping of Cardiomyocytes. A, Sample micrographic bright phase (upper panels) and fluorescent images (lower
panels) of cardiac tissue cultures at various time points. Green arrows shown at 10 d panel indicate that GFP-positive cardiomyocyte progeny start to
migrate off the tissue. T, tissue; RM, remote area. B, Outgrowth cells in remote area showing the expression of GFP (green) and c-kit (red). GFP
+/c-kit
+
cells are in yellow color; red arrows indicate the c-kit
+/GFP
2 cells which may come from the resident c-kit cells, and white arrows indicate the c-kit
2/
GFP
+ cells which are GFP myocyte progeny not acquiring the c-kit phenotype yet. Scale bar, 100 mm. C, Microscopy analysis of outgrown cells in
random scanning fields 2 microscopic views apart from the MerCreMer/ZEG heart tissue cultures at 3-week using ImageJ software. Mean data was
from cultures of 5 MerCreMer-Z/EG hearts; 8–10 cultures and 10 fields in each culture were observed.
doi:10.1371/journal.pone.0012559.g008
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length MYH6 promoter used in the present bitransgenic model
drives cardiac-specific gene recombination, resulting in the
expression of GFP only in cTnT-positive myocytes as revealed by
immunostaining and genotyping, consistent with previous findings
[38,61–65]. Richard T. Lee, who created these mice, has stained
their hearts for c-kit and found none of the c-kit
+ cells to be GFP
+,a
result confirmed by flow cytometry (R.T. Lee, personal communi-
cation). We find that outgrowth cells from bitransgenic cardiac
explants can be c-kit
+ but GFP
2 (Fig. 5), further negating an
obligatory linkage between c-kit expression and GFP positivity.
Thus, the bitransgenic mice appear to label cardiomyocytes (and
their progeny) specifically, allowing us to conclude that c-kit
+/GFP
+
cells in that model arose from dedifferentiated cardiomyocytes.
The present study shows that cardiomyocyte dedifferentiation
and proliferation can occur under highly-artificial conditions in
vitro, but does not address the crucial follow-up question of how
frequently dedifferentiation occurs in vivo, and the functional
properties of these myocyte-derived cells. Such work, which is
necessary to establish the pathophysiological importance of
dedifferentiation, would not have been motivated without the
demonstration here that spontaneous cardiomyocyte dedifferenti-
ation can occur, and can lead to cells with some key characteristics
of resident CPCs.
Materials and Methods
Dissociation, Purification, and Primary Culture of
Cardiomyocytes
All animal procedures were conducted in accordance with
humane animal care standards outlined in the NIH Guide for the
Care and Use of Experimental Animals and were approved by the
Cedars-Sinai Medical Center Animal Care and Use Committee
(IACUC2557, IACUC2424). Cardiomyocytes were isolated from
male Wistar-Kyoto rats (5–8 weeks, 70–120 g) by enzymatic
dissociation of the whole heart on a Langendorff apparatus as
previously described [66]. Heparinized animals were anaesthe-
tized by Ketamine/Xylazine (30 mg/Kg, and 6 mg/Kg, respec-
tively). Hearts were rapidly excised and cleansed to remove blood
in ice-cold Tyrode’s solution before being mounted to a
Langendorff apparatus conjugated to a pressure monitoring
device, then perfused retrogradely with the following four
oxygenated solutions in sequential order: 1. modified Tyrode’s
solution containing 1.0 mM Ca
2+ (2 min), 2. Ca
2+-free Tyrode’s
solution (2–3 min), 3. Ca
2+-free Tyrode’s solution containing 0.2
Wu ¨nsch unit/mL of collagenase made from Liberase Blendzyme 4
(Roche Molecular Biochemicals, Indianapolis, IN) for 10–15 min
depending on digesting conditions, and 4. followed by washing in
Kruftbru ¨he (KB) solution for 5 min. Digested atrium and
ventricles were cut off and minced in KB solution, pipetting to
dissociate the cells, then filtered through a nylon mesh (200 mm
pore size) to remove big pieces of undigested tissues. Isolated cells
were rinsed in KB solution and allowed to settle by gravity 3 times
to remove debris and non-cardiomyocytes. Resuspended cells in
KB solution were loaded above the top layer of a Percoll gradient
formed by 20%, 40%, and 70% Percoll and centrifuged at 100x g
for 20 min to further purify cardiomyocytes. After three washes in
KB solution, myocytes were resuspended in KB solution or in
culture media for further experiments. Modified Tyrode’s solution
contained (mmol/L): NaCl 105, KCl 5.4, KH2PO4 0.6, NaH2PO4
0.6, NaHCO3 6, KHCO3 5, CaCl2 1, MgCl2 1, HEPES 10,
glucose 5, taurine 20 (pH 7.35 with NaOH), and KB solution had
(mmol/L): KCl 20, KH2PO4 10, K
+-glutamate 70, MgCl2 1,
glucose 25, b-hydroxybutyric acid 10, taurine 20, EGTA 0.5,
HEPES 10, and 0.1% albumin (pH 7.25 with KOH). The purity
of myocyte preparations were evaluated in cells cytospun on to
22 mm cover glasses by fluorescent immunocytochemistry in
combination with high density tile confocal scanning and RT-
PCR described in later sections. Chemicals were purchased from
Sigma except for those specified.
Purified myocytes were resuspended in Medium 199 (Invitro-
gen, Carlsbad, CA) supplemented with 110 mg/L sodium
pyruvate, 0.1 mmol/L b-mercaptoethanol, 100 U/mL penicillin,
100 mg/mL streptomycin, and 5% FBS (Invitrogen) and cultured
in laminin-coated 6-well culture plates or 100-mm dishes at a
‘‘normal’’ density of ,6000 and ,9000 cells/cm
2 for ventricular
and atrial myocytes respectively, at 37 uC for one hour before
washing to remove dead and non-adherent cells, and repeated
once. Serum concentration in medium was gradually increased to
10% and 20%. On the second and third day of plating, medium
was replaced to remove dead cells, and then maintained for
prolonged culture in the presence of bFGF 0.1 ng/ml, TGF-b3
1 ng/ml, and 20% FBS in the basal IMDM medium supplement-
ed with 100 U/mL penicillin, 100 mg/mL streptomycin, and
partially changed every 4–5 days. Within the first 2,3 days, about
20–30% of cells were lost in the normal dense culture and
removed by changing the medium; the cell culture usually became
stable thereafter. This is similar to previous studies and may reflect
the apoptosis of a certain portion of myocytes. Therefore, it is
suggested that dedifferentiation functions as a reprogrammed
survival process for cardiomyocytes [54]. No AraC or other
inhibitors were used in our experiments.
Cell imaging and Tracking
In order to verify the proliferation of dedifferentiated myocytes,
cells were plated at a lower density. Numeric grid-marked
coverslips (Bellco Biotechnology, Vineland, NJ) coated with
laminin were used to track changes in identified cells during
culture, under time-lapse microscopy (Nikon TE-2000E inverted
microscope) for continuous analysis, or intermittently in an
inverted microscope (Nikon TE-2000 U), with phase contrast
objectives. Images were captured with a monochrome CCD
camera (Q-Imaging, Surrey, BC, Canada) with program suite
Image Pro Plus (Media Cybernetics, Bethesda, MD). A 3CCD
Color video camera (Sony) connected to a personal computer was
used to capture real-time images and videos of beating cells and
spheres.
Culture of Myocyte-Derived Cells
At 10 days to 2 weeks after the culture, the loosely-adherent
myocyte-derived cells (MDCs) were harvested by gentle pipetting 3
times with a disposable transfer pipette. Cells were grown in
serum-rich myocyte culture medium for the experiments detecting
the markers in fresh isolated cells. Alternatively, MDC culture
medium, which was DMEM/F12 supplemented with 0.1 mM b-
mercaptoethanol, bFGF 0.1 ng/ml, TGF-b3 1 ng/ml, 100 U/ml
penicillin, 100 mg/ml streptomycin, and 10% FBS, was used to
maintain the cells in 95% humidity, 5% CO2 at 37uC.
Labeling of Myocytes with BrdU
To study the cell cycle progression, cells were cultured in the
presence of 5-bromo-2-deoxyuridine (BrdU; Sigma; 5 mM) for
various periods starting after one day of myocyte culture before
immunoassays described previously [29]. Briefly, washed cells were
fixed with 4% paraformaldehyde and permeabilized with 0.2%
Triton-X100, followed by block with 5% normal donkey serum for
1 hour, then incubation with primary and secondary antibodies to
detect membrane molecules. Cells were washed in phosphate
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incubated in 1N HCl on ice for 10 min, and in 2N HCl at room
temperature and 37uC each for 10 min, followed by wash with
borate buffer (0.1 M, pH 8.5) at roomtemperature three times each
for 5 min. Cells were then washed in 0.1% Triton-X100 in
phosphate buffered saline and re-blocked in 5% normal donkey
serum for 30 min at room temperature, then incubated with 10 mg/
ml sheep anti-BrdU antibody (Abcam) diluted in blocking buffer for
1.5 hr at room temperature, then washed, and subsequently
incubated with Alexa Fluor 647-conjugated donkey anti-sheep
secondary antibody to detect cells with BrdU incorporation.
Fluorescent Immunocytochemistry
Cellular phenotypes were analyzed as previously described
using fluorescent immunocytochemical assays [4,66]. To test the
expression of stem cell markers, rabbit polyclonal antibody (pAb)
against c-kit (CD117) (Santa Cruz Biotechnology, Santa Cruz, CA)
or CD34 (Abcam, Cambridge, MA), mouse monoclonal antibody
(mAb) against Sca-1 (Invitrogen), and goat pAb against Thy-1
(CD90) were used as primary antibodies. Expression of cardiac
markers was assessed using antibodies including mouse mAb for a-
MHC from Abcam or Sigma, mouse mAb cTnT, and rabbit pAb
Cx43 and CD31 from Invitrogen. Primary antibodies against cell
cycle-specific molecules: Ki67, Histone H3 (phosphor-S10) (H3P)
and anti-BrdU were from Abcam. Goat polyclonal antibody
against 14-3-3g was from Santa Cruz Biotechnology, and rabbit
polyclonal p21 antibody and mouse monoclonal p53 antibody
were from Abcam. Chicken anti-GFP polyclonal antibody was
from Abcam. The specificity of antibodies was confirmed by
blocking peptides or control cells. Donkey anti-mouse, anti-rabbit,
or anti-goat, or goat-anti chicken antibodies with Alexa Fluor
conjugates were used as secondary antibodies.
Direct immunostaining was also performed to test the
expression of stem cell markers in freshly harvested MDCs using
PE-conjugated mouse mAbs against c-kit (BD Biosciences), or
FITC-conjugated CD90 (Abcam).
In MDC-formed spheres, stem cell and cardiac markers were
detected using whole-mount immunofluorescent techniques and
examined with standard and Z-stack confocal laser scan
microscopes (from Zeiss or Leica) [4]. Signals of samples from
fixation by either paraformaldehyde or cold acetone/methanol
were verified and auto-fluorescence was excluded. The acquisition
settings were optimized to avoid false positive or false negative
signal. To evaluate the purity of myocyte preparation, we used
Tile Scanning Function (Leica Confocal) to examine the whole
cover glass (22 mm diameter) after cells were subjected to
immunostaining. Images were processed by Zeiss LSM 510 or
Leica LAS software suites, and molecule expression levels were
semi-quantified by their fluorescence as described before [66–68].
Patch-Clamp Recordings
Electrophysiological properties characteristic to cardiomyocytes
in normal or dedifferentiated myocytes at 4 and 7 days and in
semi-adherent myocyte-derived cells (MDCs) were evaluated by
whole-cell patch techniques as described previously [66,69].
Inward rectifier potassium current (IK1) was recorded in voltage-
clamp mode. Resting membrane potential and cell capacitance
were also recorded as described [66,69].
RT-PCR
Reverse-transcription Polymerase Chain Reaction (RT-PCR)
was performed to test the mRNA expression of both stem cell and
cardiac markers. Extraction of total RNA from rat heart tissue,
bone marrow cells flushed from femurs, purified myocytes, MDC,
and MDC spheres, and one-step RT-PCR were carried out with
commercially available kits (Qiagen, Valencia, CA). Primer pairs
for c-kit, sca-1, CD90, CD31, CD34, a-MHC, GATA4, Nkx2.5, and
b-actin are listed in Supplemental Table S1. Additionally, one-step
real-time RT-PCR was performed to estimate the detection limit
on c-kit
+ cells sorted from bone marrow cells and serial diluted and
mixed with c-kit
- bone marrow cells or with purified myocyte
preparation.
MicroRNA Assays in Cardiomyocytes and Myocyte-
Derived Cells (MDCs)
Total RNA including MicroRNA (miRNA) was isolated from
purified cardiomyocytes or MDCs using a mirVana Paris kit
(Ambion). TaqMan Rodent MicroRNA Set A Array v2.0 which
contains 384 TaqMan MicroRNA Assays was used to detect the
expression levels of miRNAs. miRNA in 300 ng total RNA was
first reverse-transcribed into cDNA using MegaPlex RT primer
pool set A and miRNA RT kit, followed by pre-amplification of
cDNA with MegaPlex PreAmp primers pool set A and TaqMan
PreAmp master mix. cDNA was diluted and mixed with TaqMan
universal master mix before loaded into the pre-configured micro
fluidic card of miRNA. Real-time reaction was run on a 7900HT
Fast Real-Time PCR System (Applied Biosystems) and data
collected and analyzed using the accompanied SDS 2.3 software.
Two biological repeats and two technical repeats were performed.
Ct values were normalized to endogenous miRNA control Mamm
U6, and comparative 2
2DDCt method was used to evaluate the fold
change of miRNAs in MDCs vs. cardiomyocytes [70,71].
Lentiviral Transduction of Cardiac Reporter
MDC-formed spheres were transduced with the third genera-
tion lentivirus expressing eGFP under the control of cardiac a-
MHC promoter as described previously [20].
Genetic Cell Fate Mapping with Bitransgenic MerCreMer/
ZEG Mouse Cardiomyocytes
Bi-transgenic MerCreMer/ZEG mice were produced by
crossbreeding cardiomyocyte-specific MerCreMer mice [39] and
ZEG mice [40] (Jackson Laboratory) as described previously [38].
The ZEG reporter mouse carries cytomegalovirus (CMV)
enhancer/chicken b-actin promoter driving floxed b-galactosidase
and multiple stop codons, followed by eGFP. Animal genotype was
verified by standard PCR on tail genomic DNA using the
following primers: MerCreMer forward: 59- ATACCGGAGAT-
CATGCAAGC-39; MerCreMer backward: 59- AGGTGGACCT-
GATCATGGAG-39; and ZEG forward: 59- ACGGCAAGCT-
GACCCTGAAG-39; ZEG backward: 59- AAGATGGTGCG-
CTCCTGGAC-39; internal control (IL2) forward: 59- CTAGGC-
CACAGAATTGAAAGATCT-39; and internal control backward:
59- GGATGATGCTAGAATTTCCACCTAC-39. Double het-
erozygous bitransgenic MerCreMer-Z/EG mice were used for the
cell fate tracing experiments after induction of Cre recombination
for GFP labeling in cardiomyocytes by 4-OH-Tamoxifen
treatment. 4-OH-tamoxifen (Sigma), dissolved in peanut oil
(Sigma) at a concentration of 5 mg/ml, was intraperitoneally
injected into 4–6 week-old MerCreMer-Z/EG mice daily at a
dosage of 0.5 mg/d. Fourteen consecutive injections of 4-OH-
tamoxifen showed significant GFP labeling of overall cardiomy-
ocytes, as also reported previously [38]. Cardiac-specific gene
recombination (labeling of GFP to cardiomyocytes) was verified by
both genotyping in purified GFP-positive myocytes (isolated
similarly as for rat myocytes) and GFP-positive or negative MDCs
from tissue culture [20], and by immunostaining of cardiac marker
Mammalian Myocyte Plasticity
PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e12559cTnT in isolated myocytes and heart tissues. Tamoxifen-treated
bitransgenic mice were used at the age of 6–10 week and we did
not see significant difference in their capability of dedifferentiation
and proliferation, or regaining of cardiac stem cell phenotypes.
Dissociated transgenic mouse myocytes are difficult to maintain
in long-term culture. We employed established explant culture
techniques [4,72] with modifications to attain better viability of
cardiomyocytes in culture. Briefly, mouse hearts were perfused
similarly as for the rat myocyte protocol, with Ca
2+-free Tyrode’s
solution for 2 min, followed by digestion for 6–8 min in Ca
2+-free
Tyrode’s solution containing 0.15 Wu ¨nsch unit/mL of collagenase
made from Liberase Blendzyme 4, followed by washing in KB
solutionfor5 min.The heartswerecutintosmallpiecesin,1m m
3
and rinsed in KB solution for 3 times. Tissues were transferred to
laminin-coated 10 mm tissue culture dishes or 2-well chamber
CultureSlides (BD Biosciences), with M199 medium containing
100 U/mL penicillin, 100 mg/mL streptomycin, and 5% FBS
(Invitrogen) and supplements of 25 mM Blebbistatin, ITS (5 mg/ml
insulin and transferrin, 5 ng/ml selenium), and 10 mM b-hydro-
xybutyric acid for the first two days of culture. Blebbistatin, ITS,
and b-hydroxybutyric acid were replaced with bFGF 0.1 ng/ml
and TGF-b3 1 ng/ml, and FBS increased to 20% in subsequent
cultures. Medium was partially replaced every 4–5 days.
Statistics
Data were expressed as mean 6 SEM, and un-paired Student t-
test were used to evaluate the significance of differences between
groups, with a p,0.05 considered as significantly different.
Supporting Information
Table S1 Primers used for RT-PCR detection.
Found at: doi:10.1371/journal.pone.0012559.s001 (0.08 MB
PDF)
Figure S1 Purity of cardiomyocyte preparation. Myocyte
preparation was cyto-spun onto laminin-coated 22 mm cover-
glass and subjected to fluorescent immunostaining. Shown are
example composite images of high density tile scanning confocal
images. Scanning of the full preparation reveals the absence of any
non-myocyte marker. Cardiomyocyte preparations are positive to
cTnT (green, A) or a-MHC (green, B–D), but not to stem cell
marker c-kit (red, A), or endothelial cell marker CD31 (red, B), or
endothelial progenitor marker CD34 (red, C), or fibroblast marker
CD90 (red, D). Top panels are magnified views of the green
squared scanning region.
Found at: doi:10.1371/journal.pone.0012559.s002 (8.20 MB
PDF)
Figure S2 Evaluation of the detection limit of RT-PCR. A,
Standard curve constructed by plotting the Cts with the numbers
of serially-diluted c-kit
+ cells bone marrow cells. B, Amplification
plots of c-kit in cell mixtures (indicated number of c-kit
+ cells
mixed with 40,000 cardiomyocytes) with 1, 2, 5, or 10 c-kit
+ bone
marrow cells.
Found at: doi:10.1371/journal.pone.0012559.s003 (0.79 MB JPG)
Figure S3 Mitosis and Cytokinesis of Tracked Cardiomyocytes.
Example confocal images for the expressions of Ki67 (green),
Histone 3 phospho-S10 (H3P; red) in dedifferentiated myocytes
counterstained with DAPI for nuclei (blue). Panel a shows one
myocyte (on right) at G0 phase, without expression of Ki67 or
H3P, and the other myocyte (on left) at interphase with both
molecules expressed. b, c, and d: cell at prophase, anaphase, and
telophase, respectively. b and d also show cells at resting state
without Ki67 or H3P expression.
Found at: doi:10.1371/journal.pone.0012559.s004 (1.08 MB JPG)
Figure S4 Time for the first confluence of myocyte culture (A),
MDC diameter (B), and time required for sphere (Sp) to beat (C).
Found at: doi:10.1371/journal.pone.0012559.s005 (0.21 MB JPG)
Figure S5 Green fluorescence in a beating MDC sphere (please
see Online Movie S5) transduced with replication-defective
lentivirus encoding eGFP driven by cardiac a-MHC (MHY6)
promoter at 3d. Scale bar, 100 mm.
Found at: doi:10.1371/journal.pone.0012559.s006 (0.51 MB JPG)
Movie S1 MDC-formed sphere loosely adherent to the culture
layer beats spontaneously.
Found at: doi:10.1371/journal.pone.0012559.s007 (0.77 MB
WMV)
Movie S2 MDC-formed sphere loosely adherent to the culture
layer beats; shown is in higher magnification to reveal the
spontaneous activity.
Found at: doi:10.1371/journal.pone.0012559.s008 (1.02 MB
WMV)
Movie S3 MDC-formed sphere beats in suspension.
Found at: doi:10.1371/journal.pone.0012559.s009 (2.97 MB
WMV)
Movie S4 MDC-formed sphere cultured on slide continues to
exhibit spontaneous activity.
Found at: doi:10.1371/journal.pone.0012559.s010 (1.07 MB
WMV)
Movie S5 Spontaneous contraction of a MDC-formed sphere
transduced with a-MHC-eGFP lentivirus (see Figure S5).
Found at: doi:10.1371/journal.pone.0012559.s011 (3.25 MB
WMV)
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